Fabrairu 4, 2022: A Indiya, ciwon daji na iya yin mummunan tasiri na zamantakewa da tattalin arziki, yawanci yana haifar da talauci na iyali da rashin adalci na al'umma. A cikin wannan ƙasa mai ƙuruciya, an ba da rahoton yawan kamuwa da cutar sankara na shekaru da yawa har yanzu ba su da yawa. A cikin mutane biliyan 1.3, ana samun sabbin cututtukan daji fiye da miliyan 1 kowace shekara. A cikin sharuddan daidaita shekaru, wannan yana nuna kusan kashi huɗu na al'amuran maza da mata da ake gani a Yammacin Turai. Ciwon daji, a daya bangaren, shine ke da alhakin kashe mutane 600000-700000 a Indiya a cikin 2012.
Dangane da binciken IHME na Nazarin Nazari na Duniya na 2019, hoton bai bambanta ba musamman a duniya. A shekarar 2019, adadin sabbin masu kamuwa da cutar sankara ya zarce miliyan 23, sama da miliyan 18.7 a shekarar 2010. A shekarar 2019, an samu mutuwar mutane miliyan 10, daga miliyan 8.29 a shekarar 2010. Wadannan sakamakon ya nuna kashi 20.9 cikin dari da karuwar kashi 26.3 bisa dari, bi da bi. .
In both developing and developed countries, cancer is a leading cause of morbidity and mortality. The majority of the population in many low- and middle-income nations, including India, does not have access to a well-organized and well-regulated cancer care system. When a person is diagnosed with cancer, they are often forced to spend a lot of money on their own health. Such expenses can push entire families into poverty and, when paired with a lack of what are considered acceptable services, can jeopardize social stability. It can be easily said that cancer treatment in India is still in a nascent stage and huge development is required in this field.
There are two major problems cancer patients and their family members face when someone is diagnosed with cancer. One is, where will they get the best and most appropriate treatment, and two, how much money will be required for treatment? Second is the most important question, as the general population in India is still devoid of health insurance. We at CancerFax addresses both these problems. We help cancer patients find most appropriate and economical cancer treatment in India and abroad. CancerFax is working with more than 100 top cancer hospitals in 10 countries like Dana-Farber, Mayo Clinic, Boston Children’s Hospital, Sheba, Asan, Apollo, BLK, Artemis to name a few.
CAR T-Cell therapy is a breakthrough treatment for some kinds of lymphoma, leukemia and multiple myeloma. CancerFax helps patients enroll for CAR T-Cell far treatment in the USA, Israel and China. Many patients who had previously relapsed blood tumors had no evidence of cancer after CAR T-Cell therapy. It has also aided in the rehabilitation of patients who have previously failed to respond to most traditional cancer therapies. There are more than 300 ongoing clinical trials in the world’s leading cancer centers on this therapy. CAR T-Cell therapy in India is available as clinical trials now. I hope it will be available for commercial treatment very soon.
